| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc2eb439ed5dc5224878cc7e1f9cbc9d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 |
| filingDate |
2022-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b2ac932b5e64ae6a6836cdf30b57d26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c4b8bc1699ca53208f79176498eb78f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6162ce70a5691ee5d420d6e4b65b15df |
| publicationDate |
2022-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-114836532-A |
| titleOfInvention |
Application of EIF2B5 gene mutation as a target in the diagnosis of ablative leukoencephalopathy |
| abstract |
The invention discloses the application of EIF2B5 gene mutation as a target in diagnosing ablative leukoencephalopathy. The EIF2B5 gene mutation includes c.820C>T (p.R274‑) and c.913A>G (p.M305V). |
| priorityDate |
2022-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |